六分鐘行走測試應用於慢性阻塞性肺病患者運動耐力評估

The 6-minute Walk Test to Assess Exercise Capacity of Patients with Chronic Obstructive Pulmonary Disease

10.6530/YYN/2015.4.05

黃良慧(Liang-Hui Huang)；李靜怡(Chun-Yi Lee)；蔣立琦(Li-Chi Chiang)；陳玉如(Yu-Ju Chen)

最小臨床重要差異值 ； 運動耐力 ； 六分鐘行走測試 ； 慢性阻塞性肺病 ； minimal clinically important difference ； exercise tolerance ； 6-minute walk test ； chronic obstructive pulmonary disease

源遠護理

9卷3期（2015 / 09 / 01）

63 - 71

繁體中文

六分鐘行走測試（6-minute walking test）於臨床上運用，已被證明為有效及可靠的評估心、肺等疾病病人運動耐力之方法。同時，臨床上重複測量六分鐘行走測試之變化，可做為監測病人疾病嚴重度，及判斷介入措施後改變之成效。因此，為使六分鐘行走測試成為評估運動耐力與介入措施成效的客觀指標，其量化數值的界定為目前各科專家所努力研究的方向。但直至目前為止，六分鐘行走測試於各專科用的臨床最小重要差異值（minimal clinicallyimportant difference, MCID），仍存在爭議。因有鑑於六分鐘行走測試對於慢性阻塞性肺病病人臨床使用的重要，故本文將近年來所發表實證文獻，做綜整性的討論。冀望此探討結果，得以提供臨床醫護人員或研究者進行以六分鐘行走測試作為疾病嚴重度及介入成效評值的參考依據。

This article critically reviews evidence based on the value of 6MWT and it’s MCID used in patients diagnosed with chronic obstructive pulmonary disease (COPD). Measurements of the 6MWT can be used to detect clinical relevant disease progression and the effectiveness of interventions. Health care experts recommended the 6MWT as an objective tool and worthy of investment to examine its cut-point value for clinical guidance. However, the minimal clinically important difference (MCID) of 6MWT used to monitor the disease progression or to evaluate the outcomes is still under discussion. The goal is to provide recommendations on clinical application and research for the use of 6MWT in patients with COPD to monitor disease progression and effectiveness of interventions. The 6-minute walk test (6MWT) is considered to be a valid and reliable assessment tool for exercise tolerance in patients with cardiac or pulmonary diseases.

1. American Thoracic Society.American Thoracic Society statement: guidelines for the six-minute walk test.American Journal of Respiratory and Critical Care Medicine,166(1),111-117.
2. Andersson, M.,Moberg, L.,Svantesson, U.,Sundbom, A.,Johansson, H.,Emtner, M.(2011).Measuring walking speed in COPD: test-retest reliability of the 30-metre walk test and comparison with the 6-minute walk test.Primary Care Respiratory Journal,20(4),434-440.
3. Balke, B.(1963).,Civil Aeromedical Research Institute United States.
4. Belza, B.,Steele, B. G.,Hunziker, J.,Lakshminaryan, S.,Holt, L.,Buchner, D. M.(2001).Correlates of physical activity in chronic obstructive pulmonary disease.Nursing Research,50(4),195-202.
5. Cahalin, L.,Pappagianopoulos, P.,Prevost, S.,Wain, J.,Ginns, L.(1995).The relationship of the 6-min walk test to maximal oxygen consumption in transplant candidates with end-stage lung disease.Chest,108(2),452-459.
6. Carter, R.,Holiday, D. B.,Nwasuruba, C.,Stocks, J.,Grothues, C.,Tiep, B.(2003).6-minute walk work for assessment of functional capacity in patients with COPD.Chest,123(5),1408-1415.
7. Casanova, C.,Cote, C. G.,Marin, J. M.,de Torres, J. P.,Aguirre-Jaime, A.,Mendez, R.,Celli, B. R.(2007).The 6-min walking distance: Longterm follow up in patients with COPD.European Respiratory Journal,29(3),535-540.
8. Casanova, C.,Cote, C.,Marin, J. M.,Pinto-Plata, V.,de Torres, J. P.,Aguirre-Jaime, A.,Celli, B. R.(2008).Distance and oxygen desaturation during the 6-min walk test as predictors of longterm mortality in patients with COPD.Chest,134(4),746-752.
9. Celli, B. R.,Cote, C. G.,Marin, J. M.,Casanova, C.,Montes de Oca, M.,Mendez, R. A.,Cabral, H. J.(2004).The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease.The New England Journal of Medicine,350(10),1005-1012.
10. Celli, B. R.,Decramer, M.,Wedzicha, J. A.,Wilson, K. C.,Agusti, A.,Criner, G. J.,Research, A. E. T. F. f. C.(2015).An official american thoracic society/european respiratory society statement: Research questions in chronic obstructive pulmonary disease.American Journal of Respiratory and Critical Care Medicine,191(7),e4-e27.
11. Cockram, J.,Cecins, N.,Jenkins, S.(2006).Maintaining exercise capacity and quality of life following pulmonary rehabilitation.Respirology,11(1),98-104.
12. Cook, C. E.(2008).Clinimetrics Corner: The Minimal Clinically Important Change Score (MCID): A Necessary Pretense.Journal of Manual & Manipulative Therapy,16(4),E82-83.
13. Cooper, C. B.(2009).Airflow obstruction and exercise.Respiratory Medicine,103(3),325-334.
14. Cote, C. G.,Casanova, C.,Marin, J. M.,Lopez, M. V.,Pinto-Plata, V.,de Oca, M. M.,Celli, B. R.(2008).Validation and comparison of reference equations for the 6-min walk distance test.European Respiratory Journal,31(3),571-578.
15. Cote, C. G.,Pinto-Plata, V.,Kasprzyk, K.,Dordelly, L. J.,Celli, B. R.(2007).The 6-min walk distance, peak oxygen uptake, and mortality in COPD.Chest,132(6),1778-1785.
16. du Bois, R. M.,Weycker, D.,Albera, C.,Bradford, W. Z.,Costabel, U.,Kartashov, A.,King, T. E., Jr.(2011).Six-minute-walk test in idiopathic pulmonary fibrosis: test validation and minimal clinically important difference.American Journal of Respiratory and Critical Care Medicine,183(9),1231-1237.
17. Garcia-Aymerich, J.,Serra, I.,Gomez, F. P.,Farrero, E.,Balcells, E.,Rodriguez, D. A.,Anto, J. M.(2009).Physical activity and clinical and functional status in COPD.Chest,136(1),62-70.
18. Glaab, T.,Vogelmeier, C.,Buhl, R.(2010).Outcome measures in chronic obstructive pulmonary disease (COPD): Strengths and limitations.Respiratory Research,11(79)
19. Golpe, R.,Perez-de-Llano, L. A.,Mendez-Marote, L.,Veres-Racamonde, A.(2013).Prognostic value of walk distance, work, oxygen saturation, and dyspnea during 6-minute walk test in COPD patients.Respiratory Care,58(8),1329-1334.
20. Hanson, L. C.,McBurney, H.,Taylor, N. F.(2012).The retest reliability of the six-minute walk test in patients referred to a cardiac rehabilitation programme.Physiotherapy Research International,17(1),55-61.
21. Hernandes, N. A.,Wouters, E. F.,Meijer, K.,Annegarn, J.,Pitta, F.,Spruit, M. A.(2011).Reproducibility of 6-minute walking test in patients with COPD.European Respiratory Society,38(2),261-267.
22. Hill, K.,Jenkins, S. C.,Cecins, N.,Philippe, D. L.,Hillman, D. R.,Eastwood, P. R.(2008).Estimating maximum work rate during incremental cycle ergometry testing from six-minute walk distance in patients with chronic obstructive pulmonary disease.Archives of Physical Medicine and Rehabilitation,89(9),1782-1787.
23. Holland, A. E.,Hill, C. J.,Rasekaba, T.,Lee, A.,Naughton, M. T.,McDonald, C. F.(2010).Updating the minimal important difference for six-minute walk distance in patients with chronic obstructive pulmonary disease.Archives of Physical Medicine and Rehabilitation,91(2),221-225.
24. Jenkins, S. C.(2007).6-Minute walk test in patients with COPD: clinical applications in pulmonary rehabilitation.Physiotherapy,93(3),175-182.
25. Jenkins, S.,Cecins, N.(2011).Six-minute walk test: observed adverse events and oxygen desaturation in a large cohort of patients with chronic lung disease.Internal Medicine Journal,41(5),416-422.
26. Jones, P. W.,Agusti, A. G.(2006).Outcomes and markers in the assessment of chronic obstructive pulmonary disease.European Respiratory Journal,27(4),822-832.
27. Kapella, M. C.,Larson, J. L.,Patel, M. K.,Covey, M. K.,Berry, J. K.(2006).Subjective fatigue, influencing variables, and consequences in chronic obstructive pulmonary disease.Nursing Research,55(1),10-17.
28. Kessler, R.,Faller, M.,Fourgaut, G.,Mennecier, B.,Weitzenblum, E.(1999).Predictive factors of hospitalization for acute exacerbation in a series of 64 patients with chronic obstructive pulmonary disease.American Journal of Respiratory and Critical Care Medicine,159(1),158-164.
29. Kozu, R.,Jenkins, S.,Senjyu, H.,Mukae, H.,Sakamoto, N.,Kohno, S.(2010).Peak power estimated from 6-minute walk distance in Asian patients with idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease.Respirology,15(4),706-713.
30. Lacasse, Y.,Martin, S.,Lasserson, T. J.,Goldstein, R. S.(2007).Meta-analysis of respiratory rehabilitation in chronic obstructive pulmonary disease. A cochrane systematic review.Europa medicophysica,43(4),475-485.
31. McDonald, C. M.,Henricson, E. K.,Abresch, R. T.,Florence, J.,Eagle, M.,Gappmaier, E.,Peltz, S. W.(2013).The 6-minute walk test and other clinical endpoints in duchenne muscular dystrophy: Reliability, concurrent validity, and minimal clinically important differences from a multicenter study.Muscle Nerve,48(3),357-368.
32. Palange, P.,Ward, S. A.,Carlsen, K. H.,Casaburi, R.,Gallagher, C. G.,Gosselink, R.,Whipp, B. J.(2007).Recommendations on the use of exercise testing in clinical practice.European Respiratory Journal,29(1),185-209.
33. Paul, L. E.(2003).The Six-Minute Walk Test.Respiratory Care,48(8),783-785.
34. Pinto-Plata, V. M.,Cote, C.,Cabral, H.,Taylor, J.,Celli, B. R.(2004).The 6-min walk distance: change over time and value as a predictor of survival in severe COPD.European Respiratory Journal,23(1),28-33.
35. Polkey, M. I.,Spruit, M. A.,Edwards, L. D.,Watkins, M. L.,Pinto-Plata, V.,Vestbo, J.,Celli, B.(2013).Six-minute-walk test in chronic obstructive pulmonary disease: minimal clinically important difference for death or hospitalization.American Journal of Respiratory and Critical Care Medicine,187(4),382-386.
36. Poulain, M.,Durand, F.,Palomba, B.,Ceugniet, F.,Desplan, J.,Varray, A.,Prefaut, C.(2003).6-minute walk testing is more sensitive than maximal incremental cycle testing for detecting oxygen desaturation in patients with COPD.Chest,123(5),1401-1407.
37. Puhan, M. A.,Mador, M. J.,Held, U.,Goldstein, R.,Guyatt, G. H.,Schunemann, H. J.(2008).Interpretation of treatment changes in 6-minute walk distance in patients with COPD.European Respiratory Journal,32(3),637-643.
38. Puhan, M. A.,Scharplatz, M.,Troosters, T.,Steurer, J.(2005).Respiratory rehabilitation after acute exacerbation of COPD may reduce risk for readmission and mortality -- a systematic review.Respiratory Research,6(1),1-12.
39. Puhan, M.A.,Chandra, D.,Mosenifar, Z.,Ries, A.,Make, B.,Hansel, N.N.,Wise, R. A.,Sciurba, F.(2011).The minimal important difference of exercise tests in severe COPD.European Respiratory Journal,37(4),784-790.
40. Rabinovich, R. A.,Vilaro, J.,Roca, J.(2004).Evaluation exercise tolerance in COPD patients: the 6-minute walking test.Archivos de Bronconeumología,40(2),80-85.
41. Redelmeier, D. A.,Bayoumi, A. M.,Goldstein, R. S.,Guyatt, G. H.(1997).Interpreting small differences in functional status: The Six Minute Walk test in chronic lung disease patients.American Journal of Respiratory and Critical Care Medicine,155(4),1278-1282.
42. Sandland, C. J.,Morgan, M. D.,Singh, S. J.(2008).Detecting oxygen desaturation in patients with COPD: incremental versus endurance shuttle walking.Respiratory Medicine,102(8),1148-1152.
43. Singh, S. J.,Puhan, M. A.,Andrianopoulos, V.,Hernandes, N. A.,Mitchell, K. E.,Hill, C. J.,Holland, A. E.(2014).An official systematic review of the European Respiratory Society/American Thoracic Society: measurement properties of field walking tests in chronic respiratory disease.European Respiratory Journal,44(6),1447-1478.
44. Solway, S.,Brooks, D.,Lacasse, Y.,Thomas, S.(2001).A qualitative systematic overview of the measurement properties of functional walk tests used in the cardiorespiratory domain.Chest,119(1),256-270.
45. Spruit, M. A.,Pennings, H. J.,Janssen, P. P.,Does, J. D.,Scroyen, S.,Akkermans, M. A.,Wouters, E. F.(2007).Extra-pulmonary features in COPD patients entering rehabilitation after stratification for MRC dyspnea grade.Respiratory Medicine,101(12),2454-2463.
46. Spruit, M. A.,Polkey, M. I.,Celli, B.,Edwards, L. D.,Watkins, M. L.,Pinto-Plata, V.,Wouters, E. F.(2012).Predicting outcomes from 6-minute walk distance in chronic obstructive pulmonary disease.Journal of the American Medical Directors Association,13(3),291-297.
47. Spruit, M. A.,Watkins, M. L.,Edwards, L. D.,Vestbo, J.,Calverley, P. M. A.,Pinto-Plata, V.,Celli, B. R.,Wouters, E. F. M.(2010).Determinants of poor 6-min walking distance in patients with COPD: The ECLIPSE cohort.Respiratory Medicine,104(6),849-857.
48. Turner, S. E.,Eastwood, P. R.,Cecins, N. M.,Hillman, D. R.,Jenkins, S. C.(2004).Physiologic responses to incremental and self-paced exercise in COPD: A comparison of three tests.Chest,126(3),766-773.
49. Waschki, B.,Kirsten, A.,Holz, O.,Muller, K. C.,Meyer, T.,Watz, H.,Magnussen, H.(2011).Physical activity is the strongest predictor of all-cause mortality in patients with COPD: A prospective cohort study.Chest,140(2),331-342.
50. Watz, H.,Waschki, B.,Meyer, T.,Magnussen, H.(2009).Physical activity in patients with COPD.European Respiratory Journal,33(2),262-272.
51. Zwerink, M.,van der Palen, J.,van der Valk, P.,Brusse-Keizer, M.,Effing, T.(2013).Relationship between daily physical activity and exercise capacity in patients with COPD.Respiratory Medicine,107(2),242-248.

1. 竇文宏,廖靖玲,陳啟忠,郭雅玲,張喬俞,馬上閔,林碩琦(2019)。接受腦中風急性後期照護病患之物理治療成效探討：以南部某區域醫院為例。慈惠學報，15，53-62。
2. 鍾琁如,佘永吉(2021)。個別化跑步機運動訓練課程對大學視覺障礙學生健康體適能之介入成效。特殊教育季刊，159，13-28。